Key result
Repeat electroanatomic mapping in patients with arrhythmogenic RV cardiomyopathy and recurrent VT showed no significant progression of bipolar scar area (38 vs 53 cm2, P=0.09) over a mean 50 months.
Why the study?
Data characterizing structural changes of arrhythmogenic RV cardiomyopathy are limited.
Does scar area progress over time in patients with arrhythmogenic right ventricular cardiomyopathy and recurrent ventricular tachycardia?
Cohort (n=19)
Does scar area progress over time in patients with arrhythmogenic right ventricular cardiomyopathy and recurrent ventricular tachycardia?
Absolute Event Rate: 53% vs 38%
p-value: p=0.09
In ARVC patients with recurrent VT, progressive RV dilation is common and associated with baseline scar size and tricuspid regurgitation, rather than progressive scar expansion.
Scar area stable over ~4 years in ARVC with recurrent VT; leaves open RV dilation as key progression driver.
Background: Data characterizing structural changes of arrhythmogenic right ventricular (RV) cardiomyopathy are limited. Methods: Patients presenting with left bundle branch block ventricular tachycardia in the setting of arrhythmogenic RV cardiomyopathy with procedures separated by at least 9 months were included. Results: Nineteen consecutive patients (84% males; mean age 39±15 years [range, 20–76 years]) were included. All 19 patients underwent 2 detailed sinus rhythm electroanatomic endocardial voltage maps (average 385±177 points per map; range, 93–847 points). Time interval between the initial and repeat ablation procedures was mean 50±37 months (range, 9–162). No significant progression of voltage was observed (bipolar: 38 cm 2 [interquartile range (IQR), 25–54] versus 53 cm 2 [IQR, 25–65], P =0.09; unipolar: 116 cm 2 [IQR, 61–209] versus 159 cm 2 [IQR, 73–204], P =0.36) for the entire study group. There was a significant increase in RV volumes (percentage increase, 28%; 206 mL [IQR, 170–253] versus 263 mL [IQR, 204–294], P <0.001) for the entire study population. Larger scars at baseline but not changes over time were associated with a significant increase in RV volume (bipolar: Spearman ρ, 0.6965, P =0.006; unipolar: Spearman ρ, 0.5743, P =0.03). Most patients with progressive RV dilatation (8/14, 57%) had moderate (2 patients) or severe (6 patients) tricuspid regurgitation recorded at either initial or repeat ablation procedure. Conclusions: In patients with arrhythmogenic RV cardiomyopathy presenting with recurrent ventricular tachycardia, >10% increase in RV endocardial surface area of bipolar voltage consistent with scar is uncommon during the intermediate term. Most recurrent ventricular tachycardias are localized to regions of prior defined scar. Voltage indexed scar area at baseline but not changes in scar over time is associated with progressive increase in RV size and is consistent with adverse remodeling but not scar progression. Marked tricuspid regurgitation is frequently present in patients with arrhythmogenic RV cardiomyopathy who have progressive RV dilation.
No takes yet. Share an insight, caveat, or question.
Briceño et al. (2020) conducted a cohort in Arrhythmogenic right ventricular cardiomyopathy with recurrent ventricular tachycardia (n=19). Repeat electroanatomic mapping vs. Baseline electroanatomic mapping was evaluated on Progression of bipolar voltage scar area (cm2) (p=0.09). Repeat electroanatomic mapping in patients with arrhythmogenic RV cardiomyopathy and recurrent VT showed no significant progression of bipolar scar area (38 vs 53 cm2, P=0.09) over a mean 50 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: